T. Rowe Price Associates’s Magellan Health Services, Inc. MGLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,712
| Closed | -$353K | – | 3072 |
|
|
2021
Q4 | $353K | Sell |
3,712
-2,492
| -40% | -$236K | ﹤0.01% | 2538 |
|
|
2021
Q3 | $587K | Sell |
6,204
-371
| -6% | -$35.1K | ﹤0.01% | 2305 |
|
|
2021
Q2 | $619K | Sell |
6,575
-1,968
| -23% | -$185K | ﹤0.01% | 2287 |
|
|
2021
Q1 | $797K | Buy |
8,543
+913
| +12% | +$85.6K | ﹤0.01% | 2167 |
|
|
2020
Q4 | $632K | Buy |
7,630
+1,128
| +17% | +$89.2K | ﹤0.01% | 2141 |
|
|
2020
Q3 | $493K | Sell |
6,502
-485
| -7% | -$36K | ﹤0.01% | 2097 |
|
|
2020
Q2 | $510K | Sell |
6,987
-5,726
| -45% | -$367K | ﹤0.01% | 2043 |
|
|
2020
Q1 | $612K | Buy |
12,713
+129
| +1% | +$8.3K | ﹤0.01% | 1889 |
|
|
2019
Q4 | $985K | Buy |
12,584
+864
| +7% | +$60.8K | ﹤0.01% | 1891 |
|
|
2019
Q3 | $728K | Buy |
11,720
+78
| +0.7% | +$5.2K | ﹤0.01% | 1948 |
|
|
2019
Q2 | $864K | Buy |
11,642
+49
| +0.4% | +$3.29K | ﹤0.01% | 1898 |
|
|
2019
Q1 | $764K | Buy |
11,593
+60
| +0.5% | +$3.85K | ﹤0.01% | 1958 |
|
|
2018
Q4 | $656K | Buy |
11,533
+45
| +0.4% | +$2.77K | ﹤0.01% | 1977 |
|
|
2018
Q3 | $828K | Sell |
11,488
-54
| -0.5% | -$4.34K | ﹤0.01% | 1939 |
|
|
2018
Q2 | $1.11M | Buy |
11,542
+1,633
| +16% | +$157K | ﹤0.01% | 1799 |
|
|
2018
Q1 | $1.06M | Buy |
9,909
+47
| +0.5% | +$4.72K | ﹤0.01% | 1773 |
|
|
2017
Q4 | $952K | Sell |
9,862
-4
| -0% | -$354 | ﹤0.01% | 1836 |
|
|
2017
Q3 | $851K | Hold |
9,866
| – | – | ﹤0.01% | 1866 |
|
|
2017
Q2 | $719K | Sell |
9,866
-498
| -5% | -$35K | ﹤0.01% | 1914 |
|
|
2017
Q1 | $716K | Sell |
10,364
-6
| -0.1% | -$438 | ﹤0.01% | 1926 |
|
|
2016
Q4 | $780K | Sell |
10,370
-1,800
| -15% | -$115K | ﹤0.01% | 1874 |
|
|
2016
Q3 | $654K | Buy |
12,170
+3,500
| +40% | +$211K | ﹤0.01% | 1907 |
|
|
2016
Q2 | $570K | Hold |
8,670
| – | – | ﹤0.01% | 1914 |
|
|
2016
Q1 | $589K | Hold |
8,670
| – | – | ﹤0.01% | 1901 |
|
|
2015
Q4 | $535K | Buy |
8,670
+70
| +0.8% | +$3.76K | ﹤0.01% | 1927 |
|
|
2015
Q3 | $477K | Hold |
8,600
| – | – | ﹤0.01% | 1970 |
|
|
2015
Q2 | $603K | Hold |
8,600
| – | – | ﹤0.01% | 1922 |
|
|
2015
Q1 | $609K | Sell |
8,600
-1,300
| -13% | -$81.8K | ﹤0.01% | 1896 |
|
|
2014
Q4 | $594K | Buy |
9,900
+1,300
| +15% | +$76.8K | ﹤0.01% | 1891 |
|
|
2014
Q3 | $471K | Hold |
8,600
| – | – | ﹤0.01% | 1962 |
|
|
2014
Q2 | $535K | Buy |
8,600
+1,200
| +16% | +$70.5K | ﹤0.01% | 1926 |
|
|
2014
Q1 | $439K | Hold |
7,400
| – | – | ﹤0.01% | 1975 |
|
|
2013
Q4 | $443K | Hold |
7,400
| – | – | ﹤0.01% | 1959 |
|
|
2013
Q3 | $444K | Buy |
7,400
+1,000
| +16% | +$57.9K | ﹤0.01% | 1931 |
|
|
2013
Q2 | $359K | Buy |
+6,400
| New | +$335K | ﹤0.01% | 1998 |
|
T. Rowe Price Associates's MGLN Position: Q1 2022 in Review
T. Rowe Price Associates sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 3,712 shares — an estimated $353K sold.
T. Rowe Price Associates first reported a position in MGLN in Q2 2013 and held it in 35 quarters. The position peaked at $1.11M in Q2 2018. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.
- T. Rowe Price Associates reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
- T. Rowe Price Associates sold 3,712 Magellan Health Services, Inc. shares in Q1 2022, an estimated $353K.
- T. Rowe Price Associates first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 35 quarters.
- T. Rowe Price Associates's Magellan Health Services, Inc. position peaked at $1.11M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.